XML 42 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
9 Months Ended
Sep. 30, 2013
Stock-Based Compensation

10. Stock-Based Compensation

The Company recognized stock-based compensation expense on all employee and non-employee awards as follows:

For the three months
ended September 30,
For the nine months
ended September 30,
(in thousands) 2013 2012 2013 2012

Research and development

$ 119 $ 363 $ 511 $ 1,305

General and administrative

690 828 1,971 2,177

Stock-based employee compensation expense

$ 809 $ 1,191 $ 2,482 $ 3,482

The Company granted 125,000 and 1,551,400 stock options during the three and nine months ended September 30, 2013 that had a weighted-average grant date fair value of $2.47 and $1.94 per share, respectively. The Company granted 76,300 and 508,700 stock options during the three and nine months ended September 30, 2012 that had a weighted-average grant date fair value of $3.95 and $3.56 per share, respectively.

At September 30, 2013, total unrecognized compensation costs related to unvested stock options outstanding amounted to $8.8 million. The cost is expected to be recognized over a weighted-average period of 1.68 years.

On July 16, 2012, the Company extended the contractual life of 829,488 fully vested stock options held by 3 employees from 12 to 18 months, and extended the vesting period for 200,000 unvested stock options and 147,427 unvested shares of restricted stock held by 2 employees from 6 to 12 months (also see Note 3 Restructuring).

On May 31, 2013, the Company extended the contractual life of 66,667 fully vested stock options held by one employee from 3 to 12 months (see Note 3 Restructuring).

On June 14, 2013, the Company extended the contractual life of 71,167 fully vested stock options held by one employee from 3 to 12 months (see Note 3 Restructuring).

For the three months ended September 30, 2013 and 2012, the fair value of stock options was estimated on the date of grant using a Black-Scholes option valuation model with the following assumptions:

For the three months ended September 30,
2013 2012

Risk-free interest rate

1.61 - 1.74% 0.79 - 1.04%

Expected life in years

6 6

Expected volatility

94.96 - 95.64% 83.37 - 83.51%

Expected dividend yield

0 0

Stock option activity under the Company’s stock option plan for the nine months ended September 30, 2013 is as follows:

(in thousands, except share and per share data) Number of
Shares
Weighted-
Average Exercise
Price
Weighted-
Average
Contractual
Term (Years)
Aggregate
Intrinsic Value

Outstanding, December 31, 2012

7,147,303 $ 4.11

Granted

1,551,400 2.55

Exercised

(570,168 ) 1.68

Cancelled

(2,398,366 ) 4.57

Outstanding, September 30, 2013

5,730,169 $ 3.73 6.89 $ 4,255

Vested and unvested expected to vest at September 30, 2013

5,675,997 $ 3.95 4.75 $ 4,215

Options exercisable, September 30, 2013

2,996,068 $ 3.95 4.75 $ 2,203

Options exercisable, December 31, 2012

3,683,786 $ 3.56 5.28 $ 3,972

Options available for future grant

1,565,070

A summary of the status of unvested restricted stock for the nine months ended September 30, 2013 is as follows:

Number of Shares Weighted-Average
Grant Date Fair Value

Non-vested, December 31, 2012

733,739 $ 4.37

Granted

Vested

(138,814 ) 4.26

Cancelled

(163,747 ) 4.42

Non-vested, September 30, 2013

431,178 $ 4.38

At September 30, 2013, total unrecognized compensation costs related to unvested restricted stock outstanding amounted to $1.5 million. The cost is expected to be recognized over a weighted-average period of 1.32 years.